Evotec SE IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Evotec SE | EVO - NASDAQ |
$26.16-$26.16 | $21.75 | $20.90 | 20 million ADSs | 11/4/2021 |
| BofA Securities, Morgan Stanley, Citigroup, Jefferies, Cowen, RBC Capital Markets | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-10-08 Terms Added 2021-10-26 | ||||||
Evotec SE Quote & Chart - Click for current quote - EVO
IPO Boutique aggregates information on public companies and private companies, such as "EVO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Evotec SE (adapted from Evotec SE prospectus):
They are an industry-leading drug discovery and development partner for the pharmaceutical and biotechnology industry.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are an industry-leading drug discovery and development partner for the pharmaceutical and biotechnology industry.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "EVO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.